Optic neuritis

Overview

Painful monocular vision loss - subacute onset over hours to days, ranging from mild blur to near-total loss
Pain on eye movement - traction on inflamed optic nerve sheath; highly specific feature
Red desaturation (dyschromatopsia) - red objects appear washed out; colour vision often first deficit to appear
Central scotoma - most common visual field defect; papillomacular bundle involvement
Relative afferent pupillary defect (RAPD) - Marcus Gunn pupil on swinging light test; paradoxical dilation when light swung to affected eye
Uhthoff's phenomenon - temporary worsening with raised body temperature (exercise, hot bath); does NOT represent a new relapse
Fundoscopy: retrobulbar neuritis (most common) - normal disc acutely; papillitis (anterior) - swollen disc; chronic - disc pallor
💡
Classic teaching: in retrobulbar neuritis 'the patient sees nothing, and neither does the doctor' - normal fundoscopy does NOT exclude optic neuritis.

Investigations

🥇 First-line

MRI brain and orbits with gadolinium - investigation of choice; gadolinium enhancement confirms active inflammation; T2/FLAIR white matter lesions stratify MS risk
Visual acuity (Snellen), colour vision (Ishihara plates), swinging light test, visual field testing (automated perimetry), fundoscopy

🥈 Second-line

AQP4 antibodies (NMOSD), MOG-IgG (MOGAD), FBC, CRP, ESR, ANA, ANCA, ACE, syphilis serology - for atypical/bilateral/recurrent cases
Visual evoked potentials (VEPs) - prolonged P100 latency due to demyelination

Differential diagnosis

Optic neuritis vs anterior ischaemic optic neuropathy (AION)
FeatureOptic neuritisAION (GCA)
Age20-40 years>50 years (typically >70)
PainPain on eye movementHeadache, jaw claudication, scalp tenderness
Vision lossSubacute, often recoversSudden, often permanent
FundoscopyNormal disc (retrobulbar) or swollenSwollen, pale optic disc
AssociationMultiple sclerosisGiant cell arteritis
Urgent treatmentIV methylprednisoloneHigh-dose corticosteroids immediately
🚨
AION due to giant cell arteritis requires immediate high-dose corticosteroids to prevent bilateral blindness - do not miss this diagnosis.

Management

Urgent ophthalmology referral - all patients; subsequent neurology input for MS risk stratification
First-line (acute): methylprednisolone 1 g IV once daily for 3 days - speeds visual recovery but does NOT improve final visual acuity at 6-12 months; reserved for poor vision in fellow eye, bilateral involvement, or occupational necessity
Mild unilateral disease: supportive monitoring - most recover spontaneously within 4-12 weeks
MS risk: neurological referral if MRI shows demyelinating lesions; early disease-modifying therapy (e.g. interferon-beta, natalizumab) reduces risk of second demyelinating event
Uhthoff's phenomenon: advise avoidance of hot environments; reassure it is reversible and not a new relapse
⚠️
Oral prednisolone alone is contraindicated in optic neuritis - the Optic Neuritis Treatment Trial (ONTT) showed it increases recurrence rate compared to IV methylprednisolone or placebo.

Prognosis and MS risk

Most recover visual acuity to 6/9 or better within 4-12 weeks; subtle colour and contrast deficits may persist
~50% of patients with MS experience optic neuritis; ~50% of first-episode optic neuritis develop MS within 15 years
Normal MRI at presentation: ~25% MS risk at 15 years; ≥2 T2 lesions: ~72% MS risk at 15 years